Stockreport
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Intrexon Corporation (XON)
Last intrexon corp earnings: 5/10 04:05 pm
Check Earnings Report
US:NYSE Investor Relations: investors.dna.com
| IMPACT SNAPSHOT | EVENT TIME: | XON | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
XON alerts
XON alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XON alerts
High impacting INTREXON CORP news events
Weekly update
A roundup of the hottest topics
XON
NEWS
NEWS
- Intrexon Corp (NYSE: XON) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.[MarketBeat]
- Intrexon Corp (NYSE: XON) had its price target raised by analysts at JMP Securities from $42.00 to $43.00. They now have a "market outperform" rating on the stock.[MarketBeat]
- Ziopharm inks new license deal with Intrexon for cancer platforms; shares up 10% premarket [Seeking Alpha][Seeking Alpha]
- Ziopharm inks new license deal with Intrexon for cancer platforms; shares up 10% premarket [Seeking Alpha][Seeking Alpha]
- The Most Exciting Story In The $140 Billion Cannabis Boom[PR Newswire]
- More
XON
SEC Filings
SEC Filings
- 10/12/18 - Form 8-K
- 10/1/18 - Form 4
- 9/24/18 - Form 25
- XON's page on the SEC website
- More